Literature DB >> 6087501

The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia.

J Suzuki, S Fujimoto, K Mizoi, M Oba.   

Abstract

We previously published results of investigations which indicated that the combination of mannitol, which acts as a free radical scavenger, and perfluorochemicals (PFC), which have a strong oxygen-carrying capacity, can be therapeutic in cases of brain infarction. The present experiment tested the hypothesis that the effectiveness of such treatment could be increased by an optimal combination of such scavengers and other chemicals. Fifty-two dogs were used, employing the "canine model of a completely ischemic brain regulated with the perfusion method." A total of six drugs with free radical scavenger capacities were tested: mannitol, vitamin E, vitamin C, Nizofenone (Y-9197), dexamethasone (DEXA) and suloctidil (MY-103). These drugs were administered intravenously 15 minutes prior to the production of ischemia, when cerebral blood flow was reduced to one-tenth its normal volume. After one hour, recirculation was allowed and the recovery of electrical activity of the brain observed for three hours. Judged by the degree of recovery of brain electrical activity, five drugs were considered to have protective effect against brain ischemia: mannitol, vitamin E, MY-103, DEXA and Y-9197. Among these five drugs, mannitol, vitamin E and DEXA are known to be safe and easily used clinically. The combined administration of these three drugs, together with PFC, was also investigated. It was found that the speed and degree of recovery of brain electrical activity were greater when these drugs were given together than when one was administered alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087501     DOI: 10.1161/01.str.15.4.672

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Treatment of proximal vertebral artery stenosis. Vertebral to subclavian transposition.

Authors:  A Ogawa; T Yoshimoto; Y Sakurai
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Acute revascularization for progressing stroke.

Authors:  A Ogawa; T Yoshimoto; K Mizoi; T Sugawara; Y Sakurai; H Sato
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Effect of bezafibrate on the sequelae of acute experimental focal cerebral ischaemia.

Authors:  B S Aspey; S Ehteshami; C M Hurst; S Pereira; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

Review 5.  Anesthesia and monitoring for carotid endarterectomy.

Authors:  G J Theisen; B L Grundy
Journal:  Bull N Y Acad Med       Date:  1987-10

Review 6.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

7.  Treatment of cerebral arteriovenous malformation.

Authors:  T Yoshimoto; T Kayama; J Suzuki
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

8.  Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.

Authors:  K C Lowe; D C McNaughton
Journal:  Experientia       Date:  1986-12-01

9.  Experimental study on the reversibility of cerebral ischemia. Residual blood flow and duration of ischemia.

Authors:  K Mizoi; J Suzuki; H Abiko; K Ogasawara; M Oba; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

10.  Evoked potential monitoring and temporary clipping in cerebral aneurysm surgery.

Authors:  A Buchthal; M Belopavlovic; J J Mooij
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.